Literature DB >> 9427853

Serial sodium Amytal interviews in the clinical setting.

S M Fackler1, T J Anfinson, J A Rand.   

Abstract

The purpose of this study was to review the authors' experiences with serial sodium Amytal (amobarbital) interviews and to compare these results with those found in the literature. A chart review of 21 patients with suspected conversion disorder evaluated by Amytal interview was conducted retrospectively. Presenting symptoms included movement disorders, focal neurologic deficits, chronic pain, "spells," and pseudoseizures. The serial Amytal interviews confirmed the presence of psychopathology noted on admission and revealed underlying psychosocial stressors. In 2 of 21 patients, agents other than Amytal were used after the first interview. This series confirms that the serial Amytal interview has utility in the clinical setting as a diagnostic and therapeutic tool.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9427853     DOI: 10.1016/S0033-3182(97)71401-4

Source DB:  PubMed          Journal:  Psychosomatics        ISSN: 0033-3182            Impact factor:   2.386


  3 in total

1.  Clinical Manifestations and Management of Conversion Disorders.

Authors:  James A. Bourgeois; Celia H. Chang; Donald M. Hilty; Mark E. Servis
Journal:  Curr Treat Options Neurol       Date:  2002-11       Impact factor: 3.598

2.  Use of Lorazepam in drug-assisted interviews: two cases of dissociative amnesia.

Authors:  Sang-Shin Lee; Sinhyung Park; Si-Sung Park
Journal:  Psychiatry Investig       Date:  2011-11-03       Impact factor: 2.505

3.  Psychosocial interventions for conversion and dissociative disorders in adults.

Authors:  Christina A Ganslev; Ole Jakob Storebø; Henriette E Callesen; Rachel Ruddy; Ulf Søgaard
Journal:  Cochrane Database Syst Rev       Date:  2020-07-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.